IOBTQ

Io Biotech INC

-$4.6M

Net Activity

Institutions Holding

12

Popularity Rank

#9404

Avg Weight

0.00%

Total Value

$199.0K

Ownership Trend

12 institutions currently hold IOBTQ, with 4 net buyers and 17 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Significantly Decreased

Based on recent trading activity

Net Selling Institutions

17

Net Buying Institutions

4

Key Holders

View all 12 holding institutions

Quarterly Activity

Recent Activity

+$50.4K

Total Buy Value

$3.5M

Total Sell Value

New buy2
Trim5
Add2
Sold out12

4

Net Buyers

17

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding IO BIOTECH INC (IOBTQ)?
Major stakeholders currently include Ikarian Capital, LLC ($81.4K), Boothbay Fund Management, LLC ($26.5K), Gsa Capital Partners LLP ($20.0K). Based on the latest 13F filings, there are a total of 12 tracked investment funds and institutions maintaining positions in IOBTQ.
What is the overall institutional sentiment toward IOBTQ recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $4.6M, driven by 4 managers accumulating shares while 17 reduced their exposure.
Which institutions have been selling or reducing their IOBTQ positions?
In the latest period, 5 funds trimmed their holdings, and 12 managers completely exited their positions. The aggregate reported sell value was $3.5M.
Are there any notable investors adding IOBTQ to their portfolios?
Yes, buying activity remains notable. 2 institutions opened new positions in {ticker}, and 2 existing holders added to their shares. The total reported buy value for the quarter amounted to $50.4K.

Related Stocks